CN Patent

CN115947737B — 一种含硒化合物及其用途

Assigned to Nanjing Saifosi Pharmaceutical Technology Co ltd · Expires 2023-11-28 · 2y expired

What this patent protects

本发明提供了如下式(I)所示的化合物或其前药、立体异构体、顺反异构体、溶剂化物、多晶型物、同位素衍生物、药学上可接受的盐及其制备方法。本发明的化合物可以制备用于预防/治疗包括流感病毒感染的药物。

USPTO Abstract

本发明提供了如下式(I)所示的化合物或其前药、立体异构体、顺反异构体、溶剂化物、多晶型物、同位素衍生物、药学上可接受的盐及其制备方法。本发明的化合物可以制备用于预防/治疗包括流感病毒感染的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN115947737B
Jurisdiction
CN
Classification
—
Expires
2023-11-28
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Saifosi Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.